2024, Biosimilars and Insurance Coverage and Processing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2024

Biosimilars

Insurance Coverage and Processing

Towards a healthier, more equitable and innovative Indian healthcare sector

Express Pharma

NOVEMBER 1, 2024

The Union Health Ministry received an allocation of about Rs 90,650 crores in the recent budget of 2024-25, a 12.5 The increased funding for Ayushman Bharat is a definite step towards moving closer to universal health coverage, and such coverage should include modern treatments such as TAVI/ TAVR involving valve implantation or replacement.

Insurance Coverage and Processing

Insurance Coverage and Processing Biosimilars Communication Diabetes

First Drugs Selected for Price Negotiations Under The Inflation Reduction Act To Be Announced Next Week: A Recap of What That Means – The Drug Price Negotiation Program and Pending Legal Challenges

Big Molecule Watch

AUGUST 25, 2023

Congress left Medicare drug pricing to the drug manufacturers, pharmacies, and insurance plan sponsors to determine, and expressly prohibited the government from “interfering” in those private price negotiations under the so-called “Non-Interference Clause” of the Medicare Modernization Act of 2003.

Drug Pricing

Drug Pricing Biosimilars Insurance Coverage and Processing Labelling

Pharmacist Digest

Towards a healthier, more equitable and innovative Indian healthcare sector

First Drugs Selected for Price Negotiations Under The Inflation Reduction Act To Be Announced Next Week: A Recap of What That Means – The Drug Price Negotiation Program and Pending Legal Challenges

Stay Connected